Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

1,956 questions in 143 reviews · Musculoskeletal

current versions
No studies 555 · 28.4%Ungraded 107 · 5.5%Very low 255 · 13%Low 555 · 28.4%Moderate 357 · 18.3%High 127 · 6.5%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Intervention NR
Anxiety. HADS scale of 0‐21. Lower score indicated lower anxiety levels. Mean duration of · people with chronic hip, knee or hip and knee osteoarthritis
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed… (2018) · Cochrane
no estimate extracted4 studies · 704 participantsModerate
Intervention NR
SF‐36 social function. Domain of SF‐36 considered representative of quality of life: mental health domain largely covered by depression and anxiety above: scale of 0‐100. Higher score indicated improved social function. Mean duration of · people with chronic hip, knee or hip and knee osteoarthritis
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed… (2018) · Cochrane
no estimate extracted5 studies · 576 participantsLow
Intervention NR
Adverse effects of treatment · people with chronic hip, knee or hip and knee osteoarthritis
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed… (2018) · Cochrane
no estimate extractedNRNo studies
Corticosteroids (dexamethasone) vs placebo
Pain ‐ absence of pain at 12 months · septic arthritis in children taking antibiotics
Corticosteroids for septic arthritis in children (2018) · Cochrane
RR 1.33 [1.03, 1.72]1 study · 49 participantsLow
Corticosteroids (dexamethasone) vs placebo
Activities of daily living · septic arthritis in children taking antibiotics
Corticosteroids for septic arthritis in children (2018) · Cochrane
no estimate extracted0 studies · 0 participantsUngraded
Corticosteroids (dexamethasone) vs placebo
Number of participants with normal physical joint function ‐ normal function at 12 months of · septic arthritis in children taking antibiotics
Corticosteroids for septic arthritis in children (2018) · Cochrane
RR 1.32 [1.12, 1.57]1 study · 100 participantsLow
Corticosteroids (dexamethasone) vs placebo
Number of days of antibiotic treatment ‐ number of days of intravenous antibiotic treatment · septic arthritis in children taking antibiotics
Corticosteroids for septic arthritis in children (2018) · Cochrane
MD 2.772 studies · 149 participantsLow
Corticosteroids (dexamethasone) vs placebo
Length of hospital stay · septic arthritis in children taking antibiotics
Corticosteroids for septic arthritis in children (2018) · Cochrane
no estimate extracted0 studies · 0 participantsUngraded
Corticosteroids (dexamethasone) vs placebo
Total adverse events at 12 months · septic arthritis in children taking antibiotics
Corticosteroids for septic arthritis in children (2018) · Cochrane
no estimate extracted1 study · 49 participantsLow
Corticosteroids (dexamethasone) vs placebo
Serious adverse events at 12 months · septic arthritis in children taking antibiotics
Corticosteroids for septic arthritis in children (2018) · Cochrane
no estimate extracted1 study · 49 participantsLow
Acupuncture vs sham acupuncture
Pain (short‐term) WOMAC scale from: 0 to 100 (higher is worse pain). · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted2 studies · 105 participantsModerate
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Quality of life (physical component) (short‐term) SF‐36 physical component scale from 0 to 100 (higher is better quality of life). · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 137 participantsLow
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Quality of life (mental component) (short‐term) SF‐36 physical component scale from 0 to 100 (higher is better quality of life). · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 137 participantsLow
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Number of patients experiencing adverse events · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Withdrawals due to adverse events · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Serious adverse events · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs advice plus exercise
Outcomesa · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs advice plus exercise
Pain (short‐term) · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs advice plus exercise
Function (short‐term) · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs advice plus exercise
Symptom severity (modified WOMAC total) (range 0‐1,600, with lower scores indicating decrease in symptom severity) · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 28 participantsVery low
Acupuncture vs advice plus exercise
Number of patients experiencing adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs sham acupuncture
Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted2 studies · 105 participantsModerate
Acupuncture vs advice plus exercise
Withdrawals due to adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs advice plus exercise
Serious adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture as an addition to patient education vs patient education alone
Pain (short‐term) VAS scale from: 0 to 100 (higher is worse pain). · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 25 participantsUngraded
Acupuncture as an addition to patient education vs patient education alone
Function (short‐term) DRI scale from: 0 to 100 (higher is worse function). · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 25 participantsUngraded
Acupuncture as an addition to patient education vs patient education alone
Quality of life (short‐term) GSI scale from 0 to 10 (higher is worse quality of life). · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 25 participantsUngraded
Acupuncture as an addition to patient education vs patient education alone
Number of patients experiencing adverse events · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture as an addition to patient education vs patient education alone
Withdrawals due to adverse events · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture as an addition to patient education vs patient education alone
Serious adverse events · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs NSAIDs
Outcomesa · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs NSAIDs
Pain (short‐term) VAS scale from: 0 to 100 (higher is worse pain). · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 60 participantsVery low
Acupuncture vs sham acupuncture
Quality of life · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs NSAIDs
Function (short‐term) Harris function score from: 0 to 47 (higher is better function). · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 60 participantsVery low
Acupuncture vs NSAIDs
Quality of life · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs NSAIDs
Number of patients experiencing adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs NSAIDs
Withdrawals due to adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs NSAIDs
Serious adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs sham acupuncture
Number of patients experiencing adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs sham acupuncture
Withdrawals due to adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture vs sham acupuncture
Serious adverse events · patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Outcomesa · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extractedNRNo studies
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Pain (short‐term) WOMAC scale from: 0 to 100 (higher is worse pain). · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 137 participantsLow
Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone
Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · Patients with hip osteoarthritis
Acupuncture for hip osteoarthritis (2018) · Cochrane
no estimate extracted1 study · 137 participantsLow
Calcium channel blockers vs placebo
Frequency of attacks Average number of attacks/week · patients with Raynaud's phenomenon
Calcium channel blockers for primary and secondary Raynaud's phenomenon (2017) · Cochrane
no estimate extracted23 studies · 528 participantsModerate
Calcium channel blockers vs placebo
Duration of attacks Average duration per attack measured in minutes · patients with Raynaud's phenomenon
Calcium channel blockers for primary and secondary Raynaud's phenomenon (2017) · Cochrane
no estimate extracted6 studies · 69 participantsLow
Calcium channel blockers vs placebo
Severity of attacks Average severity per attack assessed on a 10‐cm visual analogue scale (0 = no symptoms, 10 = maximal severity) · patients with Raynaud's phenomenon
Calcium channel blockers for primary and secondary Raynaud's phenomenon (2017) · Cochrane
no estimate extracted18 studies · 415 participantsModerate
Calcium channel blockers vs placebo
Pain Average pain per attack, measured on a 10‐cm visual analogue scale (0 = no pain, 10 = maximal pain) · patients with Raynaud's phenomenon
Calcium channel blockers for primary and secondary Raynaud's phenomenon (2017) · Cochrane
no estimate extracted4 studies · 62 participantsLow
Calcium channel blockers vs placebo
Patient global Disability due to Raynaud's assessed on a 10‐cm visual analogue scale (0 = no disability, 10 = maximal disability) · patients with Raynaud's phenomenon
Calcium channel blockers for primary and secondary Raynaud's phenomenon (2017) · Cochrane
no estimate extracted2 studies · 92 participantsModerate
Calcium channel blockers vs placebo
Number of withdrawals due to adverse events Number of participants who dropped out of studies owing to adverse treatment effects · patients with Raynaud's phenomenon
Calcium channel blockers for primary and secondary Raynaud's phenomenon (2017) · Cochrane
RR 1.3 [0.51, 3.33]2 studies · 63 participantsLow